Abstract:OBJECTIVES:Neuroendocrine thymic tumours (NETTs) are a distinct subgroup of rare malignancies. An international, multicentre retrospective analysis was used to study the clinicopathological features, current pattern of diagnosis, treatment and outcomes of patients with NETT.METHODS:One hundred and forty-six NETT treated from 1989 to 2016 at 21 centres in China, Europe and North America were retrospectively collected and reclassified according to the World Health Organization histological type and International Thymic Malignancy Interest Group (ITMIG)/International Association for Studies in Lung Cancer (IASLC)/Union for International Cancer Control (UICC) staging. Clinicopathological features, diagnostic and therapeutic approaches and outcomes were investigated. Results in the earlier and latter halves of the study period were also compared.RESULTS:The pretreatment work-up relied exclusively on computed tomography in 85.6% (125/146) of cases. Most patients had advanced disease, with 32.2% (47/146) having lymph node involvement. Higher-grade histological type was associated with more advanced disease (P < 0.05). Induction therapies and surgical procedures were used more often in the latter half of the study. However, the complete resection rate remained unchanged, being 71.5% (98/137) in the whole group. Complete resection was associated with significantly longer 5-year overall survival (77.2% vs 51.2%; P < 0.001) than incomplete or no resection. Significant survival differences were seen with the T, N and M categories of ITMIG/IASLC/UICC staging. Poorly differentiated carcinoma, ITMIG/IASLC/UICC stage IIIa or above and incomplete or no resection were independent risk factors for worse survival. No survival difference was noted between the earlier and the latter halves of the study (58.2% vs 71.9%; P = 0.299).CONCLUSIONS:Current management similar to that for thymomas is unsatisfactory in providing disease control or long-term survival for patients with NETT. Specific diagnostic tools and novel therapeutic agents are needed to improve management outcomes of this disease.

Advances in small intestinal neuroendocrine tumor treatment

Survival Outcomes and Surgical Intervention of Small Intestinal Neuroendocrine Tumors: a Population Based Retrospective Study

Current Perspective On The Pathogenesis Of Small Intestinal Neuroendocrine Tumors: Progress In Biomarkers And Molecular Events

Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors.

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

Treatment of Primary Hepatic Neuroendocrine Tumors

Early diagnosis and treatment of gastrointestinal neuroendocrine tumors.

Progress of Drug Treatment for Gastrointestinal Neuroendocrine Neoplasm

Incidence, survival, and prognostic nomogram of patients with small intestinal neuroendocrine tumors: A SEER population-based study

Potential Effective Diagnostic Biomarker in Patients with Primary and Metastatic Small Intestinal Neuroendocrine Tumors

Recent Advances and Management

Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms with Somatostatin Analogs

Clinicopathological Features and Current Treatment Outcomes of Neuroendocrine Thymic Tumours

Influence of Lymphatic, Microvascular and Perineural Invasion on Oncological Outcome in Patients with Neuroendocrine Tumors of the Small Intestine

Advancements in medical treatment for pancreatic neuroendocrine tumors: A beacon of hope

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms

The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors

Updates on Medical Treatment for Neuroendocrine Neoplasm

Efficacy and Safety of Endoscopic Submucosal Dissection for Gastrointestinal Neuroendocrine Tumors: a 10-Year Data Analysis of Northern China.

Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population

Current Treatment Status In Pancreatic Neuroendocrine Neoplasms